[Federal Register Volume 79, Number 70 (Friday, April 11, 2014)]
[Notices]
[Pages 20216-20217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-08079]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Discretionary Advisory Committee on Heritable Disorders in
Newborns and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is
hereby given of the following meeting:
Name: Discretionary Advisory Committee on Heritable Disorders in
Newborns and Children.
Dates and Times: May 29, 2014, 9:30 a.m. to 4:30 p.m. May 30,
2014, 9:30 a.m. to 3:00 p.m.
Place: Webinar and In-Person, U.S. Pharmacopeial Convention
(USP) Headquarters, 12601 Twinbrook Parkway, Rockville, Maryland
20852.
Status: The meeting will be open to the public with attendance
limited to space availability. Participants also have the option of
viewing the meeting via webinar. Whether attending in-person or via
webinar, all participants must register for the meeting at https://www.blsmeetings.net/ACHDNCMay2014. The registration deadline is
Friday, May 2, 2014, 11:59 p.m. Eastern Time. If there are technical
problems gaining access to the Web site, please contact Anthony
Rodell, Director of Client Relations, at
[email protected].
Purpose: The Discretionary Advisory Committee on Heritable
Disorders in Newborns and Children (Committee), as authorized by
Public Health Service Act (PHS), 42 U.S.C. 217a: Advisory councils
or committees, was established to advise the Secretary of the
Department of Health and Human Services about the development of
newborn screening activities, technologies, policies, guidelines,
and programs for effectively reducing morbidity and mortality in
newborns and children having, or at risk for, heritable disorders.
Note: the Committee's recommendations regarding additional
conditions/inherited disorders for screening that have been adopted
by the Secretary are included in the Recommended Uniform Screening
Panel and constitute part of the comprehensive guidelines supported
by the Health Resources and Services Administration (HRSA). Pursuant
to section 2713 of the Public Health Service Act, codified at 42
U.S.C. 300gg-13, non-grandfathered health plans are required to
cover screenings included in the HRSA-supported comprehensive
guidelines without charging a co-payment, co-insurance, or
deductible for plan years (i.e., policy years) beginning on or after
the date that is 1 year from the Secretary's adoption of the
condition for screening.
Agenda: The meeting will include: (1) A discussion and vote on a
systematic approach to evaluate the impact of adding newborn
screening conditions on state public health systems; (2) a
presentation on the impact of the rapid implementation of electronic
health records on the Early Hearing Detection and Intervention State
programs; (3) a discussion on a potential national infrastructure to
conduct research on population-based screening; (4) a presentation
on the impact of new CPT codes for molecular diagnostics on
laboratories; and (5) updates from the Committee's Laboratory
Standards and Procedures, Follow-up and Treatment, and Education and
Training subcommittees. Tentatively, the Committee is expected to
review and/or vote on a systematic approach to evaluate the impact
of adding newborn screening conditions on state public health
systems. This tentative vote does not involve any proposed addition
of a condition to the Recommended Uniform Screening Panel.
Agenda items are subject to change as necessary or appropriate.
The agenda,
[[Page 20217]]
webinar information, Committee Roster, Charter, presentations, and
other meeting materials are located on the Advisory Committee's Web
site at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Public Comments: Members of the public may present oral comments
and/or submit written comments. Comments are part of the official
Committee record. Public comment periods are tentatively scheduled
for both May 29 and May 30, 2014. Advance registration is required
to present oral comments and/or submit written comments at https://www.blsmeetings.net/ACHDNCMay2014. The registration deadline is
Friday, May 2, 2014, 11:59 p.m. Eastern Time. Written comments must
be received by the deadline in order to be included in the May
meeting briefing book. Written comments should identify the
individual's name, address, email, telephone number, professional or
business affiliation, type of expertise (i.e., parent, researcher,
clinician, public health, etc.), and the topic/subject matter of
comments. To ensure that all individuals who have registered to make
oral comments can be accommodated, the allocated time may be
limited. Individuals who are associated with groups or have similar
interests may be requested to combine their comments and present
them through a single representative. No audiovisual presentations
are permitted. For additional information or questions on public
comments, please contact Lisa Vasquez, Maternal and Child Health
Bureau, Health Resources and Services Administration; email:
[email protected].
For Further Information Contact: Anyone interested in obtaining
other relevant information should contact Debi Sarkar, Maternal and
Child Health Bureau, Health Resources and Services Administration,
Room 18A-19, Parklawn Building, 5600 Fishers Lane, Rockville,
Maryland 20857; email: [email protected].
More information on the Advisory Committee is available at
http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Dated: April 3, 2014.
Jackie Painter,
Deputy Director, Division of Policy and Information Coordination.
[FR Doc. 2014-08079 Filed 4-10-14; 8:45 am]
BILLING CODE 4165-15-P